...BRCA2 and PSM2 mutation in the setting of metastatic pancreatic and prostate cancer. Case Presentation: The patient was ...
...BRCA2). In summary, the results of this study provide an important reference for further exploration of the genetic mech...
...BRCA2 variants, which cause hereditary breast and ovarian cancer syndrome. The decision to undergo RRSO or continue surv...
...BRCA2, 34 (41%) met familial risk criteria based on their EHRs; however, an additional 6 (7%) would have met criteria if...
...BRCA2 nonsense mutation who a durable response to fuzuloparib after NALIRIFOX chemotherapy. Her progression-free surviva...
...BRCA2, PI3KC3, and ERCC2::KLC3 fusion. The patient was treated with hormonal therapy combined with CDK4/6 inhibitors and...
...BRCA2, PALB2) and Fanconi anemia genes (n = 4). Somatic findings established that the germline variants definitively con...
...BRCA2, and 11.3 % other high-risk mutations (RAD51C, PALB2). No tubal lesions were found in 121 cases (91.7 %), while 11...
...BRCA2, PALB2, TP53 and PTEN, with germline pathogenic or likely pathogenic variants (PVs/LPVs), substantially increase t...
...BRCA2 mutation face high risks of contralateral breast cancer, and many opt for bilateral mastectomy. We used a simulati...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
